Janssen Search
Search results
Janssen Partnership and Collaboration Opportunities
We invite you to partner with us. We recognize the importance of building strong working partnerships that can advance the quality of healthcare globally, respect and protect the environment, and support our sense of responsibility to local communities. ...
Global CEO Initiative on Alzheimer’s Disease
Global CEO Initiative on Alzheimer's Disease As part of a worldwide effort to find better ways to treat the disease, Janssen joined the Global CEO Initiative on Alzheimer’s Disease (CEOi), a collaboration of public and private partnerships with ...
Kevin Wildenhaus, Ph.D.
As the Behavioral Science Lead for the Disease Interception Accelerator (DIA), Kevin Wildenhaus leads the behavioral science innovation and research efforts for the DIA and its venture focus areas. He is also heading work in perinatal depression to ...
Dave Yazujian, M.S.
As the Strategy and Operations Support Leader for the Disease Interception Accelerator (DIA), Dave Yazujian drives the development and execution of the DIA strategy, ensuring operational efficiency and effectiveness and integrating input from Janssen ...
James Merson, Ph.D.
JAMES MERSON, Ph.D. GLOBAL HEAD INFECTIOUS DISEASES James Merson, Ph.D., is the Global Therapeutic Area Head for Infectious Diseases at Janssen Research & Development, L.L.C. He is a member of the Senior R&D Leadership Team, leading the global ...
About Our Research & Development
Research & Development at Janssen: Innovations That Transform How Diseases Are Thought of, Managed, Prevented and Intercepted At the Janssen Pharmaceutical Companies of Johnson & Johnson, working on incremental improvements to healthcare is not ...
David M. Lee, M.D., Ph.D.
DAVID M. LEE, M.D., Ph.D. GLOBAL THERAPEUTIC AREA HEAD IMMUNOLOGY David M. Lee, M.D., Ph.D., is Global Immunology Therapeutic Area Head for the Janssen Pharmaceutical Companies of Johnson & Johnson where he leads a team focused on end-to-end pipeline ...
Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.
YUSRI A. ELSAYED, M.D., M.H.Sc., Ph.D. SENIOR VICE PRESIDENT GLOBAL ONCOLOGY THERAPEUTIC AREA HEAD As Global Oncology Therapeutic Area Head for Johnson & Johnson, Yusri Elsayed, M.D., M.H.SC, Ph.D. is responsible for the discovery, development and ...
Our Work
Article Type: Human Microbiome Institute Our Work We work with our partners to translate exciting ideas into therapies and other health solutions, and to create knowledge and resources that will advance the field as a whole. Our current collaborations ...
Partner with Janssen Immunology
Partner with Janssen in Immunology Partnerships established today drive the solutions of tomorrow. Our network is expansive and draws on a variety of collaborations and partnerships with experts in their fields. As a member of the Janssen Pharmaceutical ...